Tetracyclines, chloramphenicol, erythromycin, and clindamycin.
The tetracyclines are effective in the treatment of Chlamydia, Mycoplasma pneumoniae, and rickettsial infections and may also be used for gonococcal infections in patients unable to tolerate penicillins. These drugs may cause gastrointestinal irritation, photo-toxic dermatitis, diarrhea, vestibular damage, and hepatotoxicity in pregnant women. Chloramphenicol is used primarily for anaerobic infections, Haemophilus influenzae meningitis, and typhoid fever. The most important toxic effect of chloramphenicol is bone marrow suppression, which can be dose related or idiosyncratic. Erythromycin is the drug of choice for the treatment of infections caused by M. pneumoniae, Legionella species, group A beta-hemolytic streptococci, and Streptococcus pneumoniae. The frequency of serious untoward effects associated with the use of erythromycin is low; epigastric distress may occur. Clindamycin is active against Bacteroides fragilis and other anaerobic microorganisms. Pseudomembranous enterocolitis has developed in as many as 10% of patients taking this drug. The use of clindamycin should be discontinued promptly if diarrhea occurs.
Wilson
W R
WR
Division of Infectious Diseases and Internal Medicine, Mayo Clinic Jacksonville, Florida.
Cockerill
F R
FR
D001424:Bacterial Infections / Q000188:drug therapy; D002701:Chloramphenicol / Q000009:adverse effects / Q000627:therapeutic use*; D002981:Clindamycin / Q000009:adverse effects / Q000627:therapeutic use*; D004917:Erythromycin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D012282:Rickettsia Infections / Q000188:drug therapy; D013754:Tetracyclines / Q000009:adverse effects / Q000627:therapeutic use*
D013754:Tetracyclines; D002981:Clindamycin; D004917:Erythromycin; D002701:Chloramphenicol